HAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS?
Despite the decline in cardiovascular mortality rate in recent decades due to the widespread use of antihypertensive, hypocholesterolemic and antiplatelet drugs, various manifestations of ischemic heart disease (IHD) retain one-third of the mortality pattern in individuals older than 35 years [1–3]....
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«REMEDIUM GROUP» Ltd.
2017-12-01
|
| Series: | Атеротромбоз |
| Subjects: | |
| Online Access: | https://www.aterotromboz.ru/jour/article/view/132 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850182154925899776 |
|---|---|
| author | E. P. PANCHENKO |
| author_facet | E. P. PANCHENKO |
| author_sort | E. P. PANCHENKO |
| collection | DOAJ |
| description | Despite the decline in cardiovascular mortality rate in recent decades due to the widespread use of antihypertensive, hypocholesterolemic and antiplatelet drugs, various manifestations of ischemic heart disease (IHD) retain one-third of the mortality pattern in individuals older than 35 years [1–3]. In regions with a developed health system, cardiovascular mortality is gradually declining. However, death from various manifestations of IHD remains the leading cause of death among adults regardless of income level [4]. |
| format | Article |
| id | doaj-art-8daa381cc7be480eae5bec5ae3a5c38a |
| institution | OA Journals |
| issn | 2307-1109 2658-5952 |
| language | Russian |
| publishDate | 2017-12-01 |
| publisher | «REMEDIUM GROUP» Ltd. |
| record_format | Article |
| series | Атеротромбоз |
| spelling | doaj-art-8daa381cc7be480eae5bec5ae3a5c38a2025-08-20T02:17:41Zrus«REMEDIUM GROUP» Ltd.Атеротромбоз2307-11092658-59522017-12-0102324210.21518/2307-1109-2017-2-32-42116HAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS?E. P. PANCHENKO0Myasnikov Cardiology Institute of the National Medical Research Centre for Cardiology of the Ministry of Health of RussiaDespite the decline in cardiovascular mortality rate in recent decades due to the widespread use of antihypertensive, hypocholesterolemic and antiplatelet drugs, various manifestations of ischemic heart disease (IHD) retain one-third of the mortality pattern in individuals older than 35 years [1–3]. In regions with a developed health system, cardiovascular mortality is gradually declining. However, death from various manifestations of IHD remains the leading cause of death among adults regardless of income level [4].https://www.aterotromboz.ru/jour/article/view/132arterial thrombosisantiaggregantsclopidogrel |
| spellingShingle | E. P. PANCHENKO HAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS? Атеротромбоз arterial thrombosis antiaggregants clopidogrel |
| title | HAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS? |
| title_full | HAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS? |
| title_fullStr | HAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS? |
| title_full_unstemmed | HAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS? |
| title_short | HAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS? |
| title_sort | have we shifted our paradigm of clopidogrel as a mandatory drug in treatment of cardiological patients after the introduction of more powerful antiagregants |
| topic | arterial thrombosis antiaggregants clopidogrel |
| url | https://www.aterotromboz.ru/jour/article/view/132 |
| work_keys_str_mv | AT eppanchenko haveweshiftedourparadigmofclopidogrelasamandatorydrugintreatmentofcardiologicalpatientsaftertheintroductionofmorepowerfulantiagregants |